VIRP.PA
Virbac SA
Price:  
322.50 
EUR
Volume:  
1,825.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIRP.PA Relative Valuation

85.6%
Upside

As of 2024-12-14, the Relative Valuation of Virbac SA (VIRP.PA) is 598.58 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 322.50 EUR, the upside of Virbac SA based on Relative Valuation is 85.6%.

The range of the Relative Valuation is 250.89 - 1,071.55 EUR.

Range Selected
Trailing P/E multiples 12.7x - 18.5x 16.2x
Forward P/E multiples 15.3x - 16.4x 16.0x
Fair Price 250.89 - 1,071.55 598.58
Upside -22.2% - 232.3% 85.6%
322.50 EUR
Stock Price
598.58 EUR
Fair Price

VIRP.PA Relative Valuation - Historical P/E Data

Date P/E
2024-12-13 5.58
2024-12-12 5.60
2024-12-11 5.62
2024-12-10 5.71
2024-12-09 5.63
2024-12-06 5.52
2024-12-05 5.43
2024-12-04 5.46
2024-12-03 5.49
2024-12-02 5.51
2024-11-29 5.61
2024-11-28 5.55
2024-11-27 5.61
2024-11-26 5.68
2024-11-25 5.61
2024-11-22 5.60
2024-11-21 5.53
2024-11-20 5.50
2024-11-19 5.53
2024-11-18 5.48
2024-11-15 5.68
2024-11-14 5.79
2024-11-13 5.83
2024-11-12 6.02
2024-11-11 6.07
2024-11-08 6.10
2024-11-07 6.06
2024-11-06 6.03
2024-11-05 6.12
2024-11-04 6.13
2024-11-01 6.06
2024-10-31 6.01
2024-10-30 6.02
2024-10-29 6.05
2024-10-28 6.17
2024-10-25 6.14
2024-10-24 6.06
2024-10-23 6.08
2024-10-22 6.18
2024-10-21 6.00
2024-10-18 5.98
2024-10-17 6.84
2024-10-16 6.73
2024-10-15 6.70
2024-10-14 6.57
2024-10-11 6.58
2024-10-10 6.64
2024-10-09 6.61
2024-10-08 6.47
2024-10-07 6.48